Insider · CIK 0001606243

Rickey James Paul

Reports to the SEC for 3 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001606243

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	BRVEBraveheart Bio, Inc.P Purchase	Chief Financial Officer	PPurchase	+27.8K sh	$18.00	+$500K	520,927
2026-08-05	BRVEBraveheart Bio, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2024-05-20	ALPINE IMMUNE SCIENCES, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−26.8K sh	—	—	31,200
2024-05-20	ALPINE IMMUNE SCIENCES, INC.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−31.2K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−836 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−137 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−143 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−1,214 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−113K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−113K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−109K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−78K sh	—	—	0
2024-05-07	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1 sh	$7.55	+$7.55	31,201
2024-05-07	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+7,055 sh	$13.20	+$93.1K	38,256
2024-05-07	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+857 sh	$6.51	+$5,579.07	39,113
2024-05-07	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+164 sh	$11.31	+$1,854.84	39,277
2024-05-07	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+18.3K sh	$3.23	+$59.1K	57,563
2024-05-07	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+398 sh	$5.02	+$1,997.96	57,961
2024-05-07	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−1 sh	—	—	108,999
2024-05-07	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−7,055 sh	—	—	112,945
2024-05-07	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−857 sh	—	—	143
2024-05-07	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−164 sh	—	—	836
2024-05-07	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−18.3K sh	—	—	1,214
2024-05-07	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−398 sh	—	—	137
2024-01-26	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+73.8K sh	$6.51	+$480K	73,764
2024-01-26	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−73.8K sh	$22.31	−$1.65M	0
2024-01-26	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+44K sh	$11.31	+$498K	44,000
2024-01-26	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−44K sh	$25.00	−$1.1M	0
2024-01-26	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−73.8K sh	—	—	1,000
2024-01-26	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−44K sh	—	—	1,000
2024-01-25	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+236 sh	$6.51	+$1,536.36	236
2024-01-25	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−236 sh	$22.00	−$5,192	0
2024-01-25	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−236 sh	—	—	74,764
2024-01-04	ALPINE IMMUNE SCIENCES, INC.A Award	See Remarks	AAward	+31.2K sh	—	—	31,200
2024-01-04	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	See Remarks	AAward	+78K sh	—	—	78,000
2023-12-19	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+15.2K sh	$5.02	+$76.4K	15,213
2023-12-19	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−15.2K sh	$19.21	−$292K	0
2023-12-19	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−15.2K sh	—	—	535
2023-12-18	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,800 sh	$5.02	+$9,036	1,800
2023-12-18	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−1,800 sh	$19.00	−$34.2K	0
2023-12-18	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−1,800 sh	—	—	15,748
2023-12-15	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+45.4K sh	$5.02	+$228K	45,387
2023-12-15	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−45.4K sh	$19.09	−$866K	0
2023-12-15	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−45.4K sh	—	—	17,548
2023-12-14	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+11.6K sh	$5.02	+$58.2K	11,600
2023-12-14	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−11.6K sh	$19.00	−$220K	0
2023-12-14	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−11.6K sh	—	—	62,935
2023-12-06	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+6,446 sh	$3.23	+$20.8K	6,446
2023-12-06	ALPINE IMMUNE SCIENCES, INC.S Sale	See Remarks	SSale	−6,446 sh	$16.08	−$104K	0
2023-12-06	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−6,446 sh	—	—	19,500

Recent filings

Accepted (ET)
Aug 74
Rickey James Paul0001470831-26-000804
SEC(opens sec.gov)
May 204
Rickey James Paul0001626199-24-000094
SEC(opens sec.gov)
May 94
Rickey James Paul0001626199-24-000066
SEC(opens sec.gov)

Companies

Address

C/O BRAVEHEART BIO, INC. ONE LETTERMAN DR., BLDG. A, SUITE A4-300

SAN FRANCISCO, CA, 94129